Oxford Biobank Scientific Coordinator
Matt Neville is the Oxford Biobank and Bioresource Scientific Coordinator, primarily responsible for curation of the Oxford Biobank (OBB) genetic resource and facilitator of Bioresource recruit-by-genotype and recruit-by-phenotype translational research studies available to the Metabolic Research Group (MRG), the larger research community and Industry. Matt's primary research interests focus on understanding the genetic determinants of body fat function and distribution and how this may impact, and be utilised to improve, the health consequences of obesity. Other duties include primary genetic data interrogator and analyst for the MRG, DPhil student supervisor, Lecturer and dissertation supervisor on the Experimental and Translational Therapeutics MSc program and Chair of the senior academic faculty for the OCDEM building.
Matt completed his DPhil in 2000 in human molecular genetics (Ox) followed by 2 years of R&D in industry (TWT, Madison, Wisconsin, US) working on marketable novel genetic assay systems. Previous research has included the contribution of genetics to smoking addiction and cessation within the General Practice Research group (Ox) and collaborations within the Department of Gastroenterology (Ox), imputing extended HLA haplotypes for association studies with autoimmune diseases such as Irritable Bowel Disease and Behçet's disease. In 2003 Matt took on a Postdoctoral Researcher position with Prof Fredrik Karpe investigating the genetics of Adipose tissue function and the adverse consequences of Obesity and Type II Diabetes. As a progression from his previous roles within the MRG and the Oxford Biobank Matt took on the BRC funded position of Oxford Biobank and Bioresource Scientific Coordinator in 2012.
LRP5 promotes adipose progenitor cell fitness and adipocyte insulin sensitivity
Loh N. et al, (2020)
Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk.
International Multiple Sclerosis Genetics Consortium. Electronic address: email@example.com None. and International Multiple Sclerosis Genetics Consortium None., (2020), Cell, 180
Bone morphogenetic protein 2 is a depot-specific regulator of human adipogenesis.
Denton NF. et al, (2019), Int J Obes (Lond), 43, 2458 - 2468
Correction to: Bone morphogenetic protein 2 is a depot-specific regulator of human adipogenesis.
Denton NF. et al, (2019), Int J Obes (Lond), 43
The proposed systemic thermogenic metabolites succinate and 12,13-diHOME are inversely associated with adiposity and related metabolic traits: evidence from a large human cross-sectional study.
Vasan SK. et al, (2019), Diabetologia, 62, 2079 - 2087